Afatinib 30 mg

Price range: $136.00 through $391.00

Afatinib 30 mg is an advanced oral medication designed to manage non-small cell lung cancer (NSCLC) in patients with specific EGFR (epidermal growth factor receptor) mutations. As a second-generation tyrosine kinase inhibitor (TKI), it works by blocking abnormal protein signals that drive cancer cell growth and spread, helping to slow disease progression and improve patient outcomes.

This medication is typically prescribed for individuals with metastatic NSCLC or those who have not responded to previous EGFR-targeted treatments. It is taken once daily on an empty stomach, ideally one hour before or two hours after meals, as advised by a healthcare professional.

Afatinib 30 mg offers a more targeted approach than traditional chemotherapy, potentially leading to better disease control with fewer systemic side effects. However, patients may still experience mild to moderate reactions such as diarrhea, skin rashes, mouth sores, or fatigue, which should be promptly discussed with a healthcare provider.

At QuickRxHub, we ensure that Afatinib 30 mg is sourced from reputable manufacturers, maintaining high quality and safety standards. Our platform provides secure ordering, affordable pricing, and discreet delivery, making cancer care more accessible and reliable for patients in need.

Pack Size Price Piece Quantity Add To Cart
28 Tablet/s $136.00 $4.86
56 Tablet/s $266.00 $4.75
84 Tablet/s $391.00 $4.65
SKU: N/A Categories: , ,

Description

Afatinib 30 mg is a targeted oral medication used to treat non-small cell lung cancer (NSCLC), specifically in patients with epidermal growth factor receptor (EGFR) mutations. As an advanced tyrosine kinase inhibitor (TKI), Afatinib works by blocking abnormal protein signals that stimulate cancer cell growth and spread, effectively slowing or stopping disease progression.

Key Features and Benefits

  • Targeted Therapy – Afatinib 30 mg focuses on EGFR mutations, delivering a more precise approach compared to traditional chemotherapy.

  • Improved Disease Control – Studies show enhanced progression-free survival rates and better tumor reduction outcomes.

  • Convenient Oral Dosage – Taken once daily, this medication offers a simple and manageable treatment option for patients.

Medical Usage

Afatinib 30 mg is primarily prescribed for patients with metastatic NSCLC or those who have experienced progression following other EGFR-targeted therapies. It is recommended to take the medication on an empty stomach, either one hour before or two hours after meals, as directed by a healthcare provider.

Possible Side Effects

Common side effects include diarrhea, skin rash, fatigue, mouth sores, and nausea. Severe or persistent reactions should be reported to a medical professional immediately.

Why Choose QuickRxHub?

At QuickRxHub, we provide genuine Afatinib 30 mg sourced from trusted manufacturers. Our service ensures quality assurance, competitive pricing, and secure, discreet delivery directly to your doorstep.